- Report
- October 2019
- 310 Pages
Global
From €3315EUR$3,450USD£2,846GBP
- Report
- June 2019
- 220 Pages
Global
From €2104EUR$2,190USD£1,806GBP
Pentaxim is a vaccine used to protect against five diseases: diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b. It is a combination vaccine, meaning it contains antigens from all five diseases in one injection. Pentaxim is approved for use in infants and children from two months of age up to six years of age. It is administered in three doses, with the second and third doses given at least one month apart.
Pentaxim is a widely used vaccine, with many countries recommending it as part of their national immunization programs. It is also used in many private clinics and hospitals. The vaccine is available in both liquid and lyophilized forms, and is produced by several pharmaceutical companies.
Some of the companies in the Pentaxim market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Serum Institute of India. Show Less Read more